Evolent Health, Inc (EVH) Financial Statements (2024 and earlier)

Company Profile

Business Address 800 NORTH GLEBE RD, SUITE 500
ARLINGTON, VA 22203
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8741 - Management Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments188,200266,280344,348102,815228,320238,433
Cash and cash equivalents188,200266,280340,490101,008228,320238,433
Short-term investments   3,8581,807  
Restricted cash and investments14,49275,68514,43720,080154,71862,398
Receivables246,209129,012122,16771,70778,38074,705
Contract with customer, asset, after allowance for credit loss   3291,7512,102
Other undisclosed current assets29,15352,98364,85332,44824,4462,646
Total current assets:478,054523,960546,134228,801487,966378,182
Noncurrent Assets
Operating lease, right-of-use asset49,02750,20357,79972,173
Property, plant and equipment87,87481,36586,24085,15573,62850,922
Long-term investments and receivables4,47510,33521,971140,07812,8261,531
Long-term investments4,4755,45817,417139,3696,2761,531
Accounts and financing receivable, after allowance for credit loss  4,8774,5547096,550 
Intangible assets, net (including goodwill)1,165,558706,081622,806880,5231,103,160869,447
Goodwill722,774426,297354,734572,064768,124628,186
Intangible assets, net (excluding goodwill)442,784279,784268,072308,459335,036241,261
Contract with customer, asset, after allowance for credit loss    999961
Capitalized contract cost, net17,46132,62426,68736,48219,147
Restricted cash and investments12,46612,9777,2708,2606,1053,287
Other undisclosed noncurrent assets2,3781,9131,27845,54418,4889,328
Total noncurrent assets:1,339,239895,498824,0511,269,2141,234,315934,515
TOTAL ASSETS:1,817,2931,419,4581,370,1851,498,0151,722,2811,312,697
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities168,372255,186164,853105,522221,177107,892
Employee-related liabilities51,86148,27834,69125,46035,390
Accounts payable57,17496,08432,06837,488146,76042,930
Accrued liabilities111,198107,24184,50733,34348,95729,572
Deferred revenue5,75811,94414,32719,828
Debt  26,5576,269  
Deferred revenue and credits24,807
Due to related parties    798 
Contract with customer, liability20,584
Other undisclosed current liabilities259,312178,363196,04261,15026,797 
Total current liabilities:433,442445,493401,779192,769269,356132,699
Noncurrent Liabilities
Long-term debt and lease obligation412,986273,398325,86968,858  
Long-term debt, excluding current maturities412,986215,676263,343   
Liabilities, other than long-term debt68,0316,93422,93715,00418,59212,298
Deferred revenue2,533  1,330
Contract with customer, liability1,502
Deferred tax liabilities, net 2,437
Deferred income tax liabilities4,7441,4037281,942
Other liabilities4,7445,53122,20911,73217,0909,861
Operating lease, liability56,01057,72262,52668,858
Other undisclosed noncurrent liabilities43,417  292,337244,977121,394
Total noncurrent liabilities:524,434280,332348,806376,199263,569133,692
Total liabilities:957,876725,825750,585568,968532,925266,391
Temporary equity, carrying amount      
Equity
Equity, attributable to parent, including:859,417693,633619,600922,3581,143,8241,010,879
Common stock1,015908    
Treasury stock, value(21,123)(21,123)(21,123)   
Additional paid in capital1,486,8571,340,9891,229,3201,173,7081,093,174924,153
Accumulated other comprehensive loss(1,178)(362)(278)(234)(182) 
Retained earnings (accumulated deficit)(606,154)(626,779)(589,178)(251,962)50,00985,952
Other undisclosed equity, attributable to parent   859846823774
Equity, attributable to noncontrolling interest    6,68945,53235,427
Total equity:859,417693,633619,600929,0471,189,3561,046,306
TOTAL LIABILITIES AND EQUITY:1,817,2931,419,4581,370,1851,498,0151,722,2811,312,697

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1,352,013907,9571,022,433846,383627,063434,950
Revenue, net434,950
Cost of revenue(1,035,429)(20,468)  (1,243) 
Cost of goods and services sold(1,035,429)     
Policyholder benefits and claims incurred, net  (20,468)  (1,243)
Gross profit:316,584887,4891,022,433846,383625,820434,950
Operating expenses(336,464)(950,368)(1,293,057)(1,152,995)(674,543)(507,790)
Other undisclosed operating income23,52220,468  1,243 
Operating income (loss):3,642(42,411)(270,624)(306,612)(47,480)(72,840)
Nonoperating income1,4262613,0453,4953,5491,656
Investment income, nonoperating1,3694073,1643,9873,4401,656
Other nonoperating income (expense)57(146)(119)(492)109 
Interest and debt expense(25,764)(25,425)(33,126)(14,534)(5,484)(3,636)
Loss from continuing operations before equity method investments, income taxes:(20,696)(67,575)(300,705)(317,651)(49,415)(74,820)
Income (loss) from equity method investments4,56913,17910,039(9,465)(4,736)(1,755)
Other undisclosed income (loss) from continuing operations before income taxes(45,950)24,595(47,133)  171
Loss from continuing operations before income taxes:(62,077)(29,801)(337,799)(327,116)(54,151)(76,404)
Income tax expense (benefit)43,376(483)3,55321,536(40)6,637
Loss from continuing operations:(18,701)(30,284)(334,246)(305,580)(54,191)(69,767)
Loss before gain (loss) on sale of properties:(37,601)(334,246)(305,580)(54,191)(69,767)
Loss from discontinued operations (463)(7,317)    
Net loss:(19,164)(37,601)(334,246)(305,580)(54,191)(69,767)
Net income attributable to noncontrolling interest    3,6091,5339,102
Other undisclosed net loss attributable to parent      
Net loss attributable to parent:(19,164)(37,601)(334,246)(301,971)(52,658)(60,665)
Preferred stock dividends and other adjustments      
Other undisclosed net income available to common stockholders, basic      
Net loss available to common stockholders, diluted:(19,164)(37,601)(334,246)(301,971)(52,658)(60,665)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(19,164)(37,601)(334,246)(305,580)(54,191)(69,767)
Other undisclosed comprehensive loss  (84)(44)(52)(182) 
Comprehensive loss:(19,164)(37,685)(334,290)(305,632)(54,373)(69,767)
Comprehensive income, net of tax, attributable to noncontrolling interest    3,6091,5339,102
Other undisclosed comprehensive loss, net of tax, attributable to parent(816)     
Comprehensive loss, net of tax, attributable to parent:(19,980)(37,685)(334,290)(302,023)(52,840)(60,665)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: